Clinical Study | Office of Clinical Research

A5415 A Limited-Center, Prospective, Double-Blind, Placebo-Controlled Study To Evaluate The Effects Of Cenicriviroc Mesylate On Arterial Inflammation In People Living With Hiv

Posted Date: Apr 25, 2023

Investigator: Moises Huaman
Specialties:
Type of Study: Drug

A Limited-Center, Prospective, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living with HIV

Criteria:

Have Hiv Infection Current Hiv Rna <20 Current Cd4+ >200 On Stable Antiretroviral Therapy No Myocardial Infarction Or Unstable Angina Within 90 Days Hepatitis C Negative No Untreated Hepatitis B No Active Malignancy (Cancer) No Ch

Keywords:

Hiv, Inflammation

For More Information:

Michelle Saemann
513-584-2245
saemanmd@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List